Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3014)
All Articles published online
|
Jan 14, 2006 (publication date) through Jun 4, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Rana S, Attri S, Vaiphei K, Pal R, Attri A, Singh K. Role of N-acetylcysteine in rifampicin-induced hepatic injury of young rats. World J Gastroenterol 2006; 12(2): 287-291 [PMID: 16482631 DOI: 10.3748/wjg.v12.i2.287] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i2/287.htm |
| Number | Citing Articles |
| 1 |
R. Pal, S.V. Rana, K. Vaiphei, K. Singh. Isoniazid-rifampicin induced lipid changes in rats. Clinica Chimica Acta 2008; 389(1-2): 55 doi: 10.1016/j.cca.2007.11.028
|
| 2 |
Gabriel A. Gutiérrez-Rebolledo, A. Georgina Siordia-Reyes, Mariana Meckes-Fischer, Adelina Jiménez-Arellanes. Hepatoprotective properties of oleanolic and ursolic acids in antitubercular drug-induced liver damage. Asian Pacific Journal of Tropical Medicine 2016; 9(7): 644 doi: 10.1016/j.apjtm.2016.05.015
|
| 3 |
Dawit A. Ejigu, Solomon M. Abay. N-Acetyl Cysteine as an Adjunct in the Treatment of Tuberculosis. Tuberculosis Research and Treatment 2020; 2020: 1 doi: 10.1155/2020/5907839
|
| 4 |
Charan Singh, L.V. Seshu Kumar Koduri, U. Arun Kumar, Tara Datt Bhatt, Vivek Kumar, Masilamani Elizabeth Sobhia, Sarasija Suresh. Attenuation potential of rifampicin–phospholipid complex in murine hepatotoxicity model. Journal of Drug Delivery Science and Technology 2015; 30: 225 doi: 10.1016/j.jddst.2015.10.021
|
| 5 |
S. V. Rana, R. Pal, K. Vaiphei, R. P. Ola, K. Singh. Hepatoprotection by carotenoids in isoniazid–rifampicin induced hepatic injury in rats. Biochemistry and Cell Biology 2010; 88(5): 819 doi: 10.1139/O10-023
|
| 6 |
Shadi Baniasadi, Parivash Eftekhari, Payam Tabarsi, Fanak Fahimi, Mohammad Reza Raoufy, Mohammad Reza Masjedi, Ali Akbar Velayati. Protective effect of N-acetylcysteine on antituberculosis drug-induced hepatotoxicity. European Journal of Gastroenterology & Hepatology 2010; 22(10): 1235 doi: 10.1097/MEG.0b013e32833aa11b
|
| 7 |
K. N. Woodward. Toxicological Effects of Veterinary Medicinal Products in Humans. 2012; : 273 doi: 10.1039/9781849735483-00273
|
| 8 |
Debarpita Saha, Sangita Paul, Utkarsh Gaharwar, Anshu Priya, Anindita Neog, Archana Singh, Binukumar BK. Cdk5-Mediated Brain Unfolded Protein Response Upregulation Associated with Cognitive Impairments in Type 2 Diabetes and Ameliorative Action of NAC. ACS Chemical Neuroscience 2023; 14(15): 2761 doi: 10.1021/acschemneuro.3c00341
|
| 9 |
Ghanshyam Upadhyay, Abhai Kumar, Mahendra Pratap Singh. Effect of silymarin on pyrogallol- and rifampicin-induced hepatotoxicity in mouse. European Journal of Pharmacology 2007; 565(1-3): 190 doi: 10.1016/j.ejphar.2007.03.004
|
| 10 |
Chong Shen, Xiangdong Cheng, Donghui Li, Qin Meng. Investigation of rifampicin-induced hepatotoxicity in rat hepatocytes maintained in gel entrapment culture. Cell Biology and Toxicology 2009; 25(3): 265 doi: 10.1007/s10565-008-9076-8
|
| 11 |
Evan Prince Sabina, Jerine Peter S, Prathap S, A Geetha. A comparison of hepatoprotective activity of Bacoside to Silymarin treatment against a combined Isoniazid and Rifampin-induced hepatotoxicity in female Wistar rats. Journal of Histotechnology 2019; 42(3): 128 doi: 10.1080/01478885.2019.1638535
|
| 12 |
Mehmet Mustafa Erdogan, Mehmet Ali Erdogan, Suleyman Koc, Alper Yalcin, Ahmet Turk, Esra Akkus Yetkin. Hepatoprotective effects of N-acetylcysteine on liver injury by irisin upregulation and oxidative stress reduction in diabetic rats. Egyptian Liver Journal 2023; 13(1) doi: 10.1186/s43066-023-00271-x
|
| 13 |
Kívia De Andrade, Fabiana Moura, John Dos Santos, Orlando De Araújo, Juliana De Farias Santos, Marília Goulart. Oxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-Acetylcysteine. International Journal of Molecular Sciences 2015; 16(12): 30269 doi: 10.3390/ijms161226225
|
| 14 |
Christina Cahill, James Joseph Phelan, Joseph Keane. Understanding and Exploiting the Effect of Tuberculosis Antimicrobials on Host Mitochondrial Function and Bioenergetics. Frontiers in Cellular and Infection Microbiology 2020; 10 doi: 10.3389/fcimb.2020.00493
|
| 15 |
Olayinka A. Adebayo, Omolola A. Adesanoye, Olalekan A. Abolaji, Aderemi O. Kehinde, Oluwatosin A. Adaramoye. First-line antituberculosis drugs disrupt endocrine balance and induce ovarian and uterine oxidative stress in rats. Journal of Basic and Clinical Physiology and Pharmacology 2018; 29(2): 131 doi: 10.1515/jbcpp-2017-0087
|
| 16 |
Radhika Sharma, Ramneek Kaur, Manishi Mukesh, Vijay L. Sharma. Assessment of hepatotoxicity of first-line anti-tuberculosis drugs on Wistar rats. Naunyn-Schmiedeberg's Archives of Pharmacology 2018; 391(1): 83 doi: 10.1007/s00210-017-1434-8
|
| 17 |
Murat Deniz, Huseyin Borman, Tamer Seyhan, Mehmet Haberal. An effective antioxidant drug on prevention of the necrosis of zone of stasis: N-acetylcysteine. Burns 2013; 39(2): 320 doi: 10.1016/j.burns.2012.06.015
|
| 18 |
Deepasree Sukumaran, P. Usharani, G.K. Paramjyothi, M.V.S. Subbalaxmi, K. Sireesha, Mohammed Abid Ali. A study to evaluate the hepatoprotective effect of N- acetylcysteine on anti tuberculosis drug induced hepatotoxicity and quality of life. Indian Journal of Tuberculosis 2023; 70(3): 303 doi: 10.1016/j.ijtb.2022.05.012
|
| 19 |
Neha Vithal Bhilare, Suneela Sunil Dhaneshwar, Kakasaheb Ramoo Mahadik. Amelioration of hepatotoxicity by biocleavable aminothiol chimeras of isoniazid: Design, synthesis, kinetics and pharmacological evaluation. World Journal of Hepatology 2018; 10(7): 496-508 doi: 10.4254/wjh.v10.i7.496
|
| 20 |
M. Muthulinga. Antihepatotoxic Effects of Boerhaavia diffusa L. on Antituberculosis Drug, Rifampicin Induced Liver Injury in Rats. Journal of Pharmacology and Toxicology 2008; 3(2): 75 doi: 10.3923/jpt.2008.75.83
|
| 21 |
Chote Luangchosiri, Ammarin Thakkinstian, Sermsiri Chitphuk, Wasana Stitchantrakul, Supanna Petraksa, Abhasnee Sobhonslidsuk. A double-blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug-induced liver injury. BMC Complementary and Alternative Medicine 2015; 15(1) doi: 10.1186/s12906-015-0861-7
|
| 22 |
Sude Eminzade, Fikriye Uras, Fikret V Izzettin. Silymarin protects liver against toxic effects of anti-tuberculosis drugs in experimental animals. Nutrition & Metabolism 2008; 5(1) doi: 10.1186/1743-7075-5-18
|
| 23 |
M Singh, P Sasi, V H Gupta, G Rai, D N Amarapurkar, P P Wangikar. Protective effect of curcumin, silymarin and N-acetylcysteine on antitubercular drug-induced hepatotoxicity assessed in an in vitro model. Human & Experimental Toxicology 2012; 31(8): 788 doi: 10.1177/0960327111433901
|